Caris Life Sciences
(NASDAQ) CAI
Caris Life Sciences Financials at a Glance
Market Cap
$4.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$907.29M
Net Income (TTM)
$33.98M
EPS (TTM)
-$1.47
P/E Ratio
-11.92
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$17.12
Volume
1,010,499.093
Open
$17.43
Price
$17.12
Volume
1,010,499.093
Open
$17.43
Previous Close
$17.47
Daily Range
$16.73 - $17.43
52-Week Range
$14.19 - $42.50
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$17.12
Volume
1,010,499.093
Open
$17.43
Previous Close
$17.47
Daily Range
$16.73 - $17.43
52-Week Range
$14.19 - $42.50
Estimated Earnings Date
Aug 11, 2026
CAI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Caris Life Sciences
Industry
Biotechnology
Sector
Health CareEmployees
1,846
CEO
David Dean Halbert
Website
www.carislifesciences.comHeadquarters
Irving, TX 75039, US
CAI Financials
Key Financial Metrics (TTM)
Gross Margin
68.72%
Operating Margin
15.91%
Net Income Margin
3.75%
Return on Equity
6.47%
Return on Capital
4.72%
Return on Assets
2.92%
Earnings Yield
-8.39%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
282.68M
Volume
1.01M
Avg. Volume
2.74M
Financials (TTM)
Gross Profit
$623.45M
Operating Income
$144.32M
EBITDA
$104.48M
Operating Cash Flow
$147.37M
Capital Expenditure
-$23.91M
Free Cash Flow
$123.46M
Cash & ST Invst.
$823.46M
Total Debt
$430.96M
Caris Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$216.17M
+78.8%
Gross Profit
$141.35M
+147.7%
Gross Margin
65.39%
N/A
Market Cap
$4.94BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.79M
N/A
Employees
1,769
N/A
Net Income
-$510.00K
+99.5%
EBITDA
$10.35M
+112.5%
Quarterly Fundamentals
Total Cash
$823.46M
+2363.5%
Total Debt
$430.96M
+2.7%
Accounts Receivable
$90.52M
+12.9%
Inventory
$0.00
-100.0%
Long Term Debt
$424.95M
+20.1%
Short Term Debt
$6.01M
-90.9%
Return on Assets
2.92%
N/A
Return on Invested Capital
14.17%
N/A
Free Cash Flow
$22.53M
+166.2%
Operating Cash Flow
$32.88M
+204.9%